FDA Inspection 971381 — BASF Corporation
The FDA completed an inspection of BASF Corporation on May 18, 2016 in Washington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Washington, NJ (United States)